Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.
Itzykson
Raphael
R
Clinique Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris, France.
Thépot
Sylvain
S
Quesnel
Bruno
B
Dreyfus
Francois
F
Beyne-Rauzy
Odile
O
Turlure
Pascal
P
Vey
Norbert
N
Recher
Christian
C
Dartigeas
Caroline
C
Legros
Laurence
L
Delaunay
Jacques
J
Salanoubat
Célia
C
Visanica
Sorin
S
Stamatoullas
Aspasia
A
Isnard
Francoise
F
Marfaing-Koka
Anne
A
de Botton
Stephane
S
Chelghoum
Youcef
Y
Taksin
Anne-Laure
AL
Plantier
Isabelle
I
Ame
Shanti
S
Boehrer
Simone
S
Gardin
Claude
C
Beach
C L
CL
Adès
Lionel
L
Fenaux
Pierre
P